Results 141 to 150 of about 384,012 (260)

Extracellular Vesicles in Cardiac Amyloidosis: From Pathogenesis to Clinical Applications

Diagnostics
Cardiac amyloidosis is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded proteins, most commonly immunoglobulin light chains (AL) or transthyretin (ATTR), with rarer forms occurring less frequently. AL amyloidosis arises from
Ashot Batikyan, Donclair Brown, Zainab Elahmadi, Joo Hee Park, Ashwin Ragupathi, Petras Lohana, Panagiotis Zoumpourlis, Priyansh Shah, Modak Vishakha, Martin Mcintosh, Michail Kladas, Priyanka Gokulnath, Michail Spanos   +12 more
doaj   +1 more source

Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort study

Quality of Life Research
Transthyretin amyloid cardiomyopathy (ATTR-CM) is associated with severely impaired health-related quality of life (HRQL). HRQL is an independent predictor of outcome in heart failure (HF), but data on patients with ATTR-CM is scarce.
M. Poledniczek, C. Kronberger, R. Willixhofer, N. Ermolaev, B. Cherouny, T. Dachs, R. Rettl, C. Binder-Rodriguez, L. Camuz Ligios, B. Gregshammer, A. Kammerlander, Johannes Kastner, J. Bergler-Klein, F. Duca, R. Badr Eslam   +14 more
semanticscholar   +1 more source

Cerebrovascular Involvement in Transthyretin Amyloid Cardiomyopathy

Journal of Clinical Medicine
Background: Intracardiac thrombosis is common in transthyretin amyloid cardiomyopathy (ATTR-CM), and patients are at risk for thromboembolic events. However, silent cerebral infarcts and the extent of cerebral small vessel disease in patients with cardiac amyloidosis are unknown.
Lukas Haider, Lore Schrutka, Emanuele Tommasino, Nicolas Avanzini, Sven Hauck, Nikolaus Nowak, Christian Hengstenberg, Diana Bonderman, Majda Thurnher   +8 more
openaire   +2 more sources

Case Report: A rare transthyretin mutation p.D58Y in a Chinese case of transthyretin amyloid cardiomyopathy

Frontiers in Cardiovascular Medicine
Hereditary transthyretin amyloid (ATTRv) cardiomyopathy (CM) is caused by mutations in the TTR gene. TTR mutations contribute to TTR tetramer destabilization and dissociation, leading to excessive deposition of insoluble amyloid fibrils in the myocardium
Jibin Lin, Jibin Lin, Jibin Lin, Jiangtong Peng, Jiangtong Peng, Jiangtong Peng, Bingjie Lv, Bingjie Lv, Bingjie Lv, Zheng Cao, Zhijian Chen, Zhijian Chen, Zhijian Chen   +12 more
doaj   +1 more source

Cardiac amyloidosis

Annales Academiae Medicae Silesiensis
Amyloidosis is a rare disease characterized by an abnormal accumulation of the amyloid protein in tissues. Amyloidosis can be divided into two main subtypes: transthyretin amyloidosis (ATTR-CA) and immunoglobulin light chain amyloidosis (AL-CA ...
Magdalena Balwierz, Bartosz Gruchlik, Katarzyna Mizia-Stec   +2 more
doaj   +1 more source

Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan

ESC Heart Failure
This study aimed to describe baseline characteristics and adherence among patients with transthyretin amyloid cardiomyopathy (ATTR‐CM) treated with tafamidis (VYNDAQEL®) in Japan using the Japanese Medical Data Vision (MDV) database.
Takao Kato, M. Ines, M. Minamisawa, D. Benjumea, D. Keohane, J. Alvir, R. Kim, Yong Chen, T. Peixoto, Matthew T. Kent, Jenifer Wogen, Tomonori Ishii, Aaron Crowley, Toshiya Sugino, Yasuhiro Izumiya   +14 more
semanticscholar   +1 more source

Amyloid Cardiomyopathy Mimicking Reverse Takotsubo Cardiomyopathy [PDF]

Heart, Lung and Circulation, 2016
O. Gibbs, J. Otton, A. Makris, J. French
openaire   +1 more source

Transthyretin Amyloid Cardiomyopathy

Journal of the American College of Cardiology, 2019
Frederick L. Ruberg, Martha Grogan, Mazen Hanna, Jeffery W. Kelly, Mathew S. Maurer   +4 more
openaire   +1 more source

Usefulness of Regional Longitudinal Strain to Identify Transthyretin Amyloid Cardiomyopathy. [PDF]

Circ Rep
Usuku H, Yamamoto E, Imamura K, Higashi R, Nozuhara A, Oike F, Kuyama N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Arima Y, Oda S, Kawano H, Matsuzawa Y, Izumiya Y, Ueda M, Tanaka Y, Tsujita K.   +18 more
europepmc   +1 more source

Catheter Ablation and Device Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Review of Non-Pharmacological Therapy. [PDF]

J Arrhythm
Kanazawa H, Hoshiyama T, Kaneko S, Kawahara Y, Tsuruta Y, Tsurusaki Y, Matsunaga K, Tamanoi S, Kuyama N, Usuku H, Yamamoto E, Izumiya Y, Tsujita K.   +12 more
europepmc   +1 more source